Search clinical trials for: TG103

Total 16 results

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Recruiting

A Study of TG103 Injection in Overweight or Obesity

Overweight or Obesity

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity

Obesity | Overweight
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of TG103 in Subjects With Type 2 Diabetes

Type 2 Diabetes
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Non-diabetic Overweight or Obesity

Overweight or Obesity

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase 3 Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study of TG103 in Chinese Healthy Adult Subjects

Healthy

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes

Diabetes

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects

Healthy Male Subjects

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

China
Edward Patz

Active, not recruiting

Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)

Non-small Cell Lung Cancer

United States
TargeGen

Completed

Safety of TG100-115 for Heart Attack Treated With Angioplasty

Myocardial Infarction

United States
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase 3 Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Taro Pharmaceuticals USA

Completed

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Tinea Pedis

United States
Jeffrey Clarke
Merck Sharp & Dohme LLC; Grid Therapeutics

Suspended

Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | Metastatic NSCLC | Recurrent Non Small Cell Lung Cancer

United States
Robert Feldman

Terminated

The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS) (ASSISTS)

Glaucoma

United States

Search clinical trials for: TG103

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations